Tower Research Capital LLC (Trc) In8 Bio, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in In8 Bio, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 13,189 shares of INAB stock, worth $3,297. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,189
Previous 3,785
248.45%
Holding current value
$3,297
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding INAB
# of Institutions
27Shares Held
7.62MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD1.67MShares$418,6590.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$355,9740.0% of portfolio
-
683 Capital Management, LLC New York, NY1.35MShares$337,5760.03% of portfolio
-
Sigma Planning Corp Ann Arbor, MI851KShares$212,8200.01% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT829KShares$207,2940.0% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $6.13M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...